These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 90732)

  • 1. Burned patients and immunoregulation.
    Markley K
    J Trauma; 1979 Nov; 19(11 Suppl):891-2. PubMed ID: 90732
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-Pseudomonas immunoglobulin. IV. Combined anti-Pseudomonas immunoglobulin and Pseudomonas vaccine immunotherapy of burned patients--clinical investigations.
    Sakiel S; Schiller B; Buchowicz I; Lysakowska E; Tomanek E; Kruczałowa M; Przewdziecka M
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):523-8. PubMed ID: 6534319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reduction of Pseudomonas septicemias in burned patients by the immune process.
    Pierson C; Feller I
    Surg Clin North Am; 1970 Dec; 50(6):1377-83. PubMed ID: 4922825
    [No Abstract]   [Full Text] [Related]  

  • 4. Reagins from orally immunized animals. I. Nature and protection effect.
    Levanon Y; Rossetini SM
    Prog Immunobiol Stand; 1970; 4():347-51. PubMed ID: 4098271
    [No Abstract]   [Full Text] [Related]  

  • 5. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
    Lieberman MM; Ayala E
    J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization against Pseudomonas in infection after thermal injury.
    Wesley J; Fisher A; Fisher MW
    J Infect Dis; 1974 Nov; 130 Suppl(0):S152-8. PubMed ID: 4138646
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pyocyanic infection in burned patients. Immunitary protection].
    Moyen EN; Lesage D; Romano P
    Nouv Presse Med; 1972 Apr; 1(14):947-50. PubMed ID: 4623061
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudomonas vaccine and hyperimmune plasma for burned patients.
    Feller I; Pierson C
    Arch Surg; 1968 Aug; 97(2):225-9. PubMed ID: 5657428
    [No Abstract]   [Full Text] [Related]  

  • 9. Utilization of antipiocianaeus and antistaphylococcus vaccine in the treatment of the severe burned patients.
    Rossi R; Candiani P
    Panminerva Med; 1983; 25(3):167-8. PubMed ID: 6669390
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
    Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obtaining the homologous hyperimmune preparations from the blood of immunized donors - anti-coli (anti-Escherichia) and antitoxic antipyocyanotic plasma].
    Skurkovich SV; Likhoded VG; Krokhina MA; Temper RM; Demidova NV
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):51-3. PubMed ID: 417340
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response of germ-free and monocontaminated burned animals.
    Hummel RP; MacMillan BG; Altemeier WA; Hill EO
    J Trauma; 1966 May; 6(3):368-90. PubMed ID: 5934281
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of human anti-Pseudomonas immunoglobulins in treatment of children with burns].
    Bukowska D; Wegrzynowicz Z; Rudowski W; Kraj M; Rosiek A; Gardzińska E; Popiel D
    Pol Tyg Lek; 1996 Jun; 51(23-26):331-3. PubMed ID: 9273523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1980 Dec; 2(8207):1263-5. PubMed ID: 6108445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunostaging and wound infection].
    Mücke D
    Zentralbl Chir; 1982; 107(11):648-54. PubMed ID: 6181628
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral immunization against colienteritis with streptomycin-dependent E. coli. II. Comparison of the effectivity of vaccines from live streptomycin-dependent and killed EC-0111 B4 bacteria by testing the agglutinin formation in mice and rabbits, the bactericidal activity of rabbit serums and the passive protection trial in mice].
    Koch H; Linde K; Kittlick M; Stelzner A
    Zentralbl Bakteriol Orig; 1969; 211(4):466-75. PubMed ID: 4916987
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of active and passive antibacterial immunization on skin allograft survival in rabbits.
    Liska M; Hatala M
    Folia Biol (Praha); 1979; 25(1):70-5. PubMed ID: 107050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological characteristics and pathogenesis of experimental pyocyanic sepsis].
    Baliabin AA
    Arkh Patol; 1973; 35(3):26-31. PubMed ID: 4128886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of E. coli endotoxin in the pathogenesis of burn toxemia].
    Fedorov NA; Golosova TV; Nedoshivina RV; Murashova NS
    Eksp Khir Anesteziol; 1974; 0(4):41-4. PubMed ID: 4605944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.